Original Research

Published on 22 Feb 2024

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

in Pharmacology of Anti-Cancer Drugs

Ningning Yan
Sanxing Guo
Siyuan Huang
Huixian Zhang
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331128

2,235 views

Correction

Accepted on 20 Feb 2024

Corrigendum: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

in Pharmacology of Anti-Cancer Drugs

YouCai Yi
Rui Liang
Xiao-Yu Chen
Hui-Ning Fan
Ming Chen
Jin-Shui Zhu
Jing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1387599

174 views

Case Report

Published on 15 Feb 2024

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy

in Pharmacology of Anti-Cancer Drugs

Hirofumi Ohmura
Taro Tobo
Yuki Ando
Takaaki Masuda
Koshi Mimori
Koichi Akashi
Eishi Baba

Frontiers in Oncology

doi 10.3389/fonc.2024.1340419

1,535 views
1 citation

Original Research

Published on 15 Feb 2024

Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC

in Pharmacology of Anti-Cancer Drugs

Huan Gao
Xiaoni Zhang
Mengdi Ren
Aimin Jiang
Na Liu
Jingjing Wang
Xiaoqiang Zheng
Xuan Liang
Zhiping Ruan
Tao Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1346225

1,335 views

Review

Published on 12 Feb 2024

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches

in Pharmacology of Anti-Cancer Drugs

Karanpreet Bhatia
Vedant Sandhu
Mei Hsuan Wong
Prasad Iyer
Shruti Bhatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1275251

2,998 views
3 citations

Brief Research Report

Published on 02 Feb 2024

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

in Pharmacology of Anti-Cancer Drugs

Norman Fultang
Ashley M. Schwab
Sophia McAneny-Droz
Alexander Grego
Stephanie Rodgers
Brian Vidal Torres
Diane Heiser
Peggy Scherle
Neha Bhagwat

Frontiers in Oncology

doi 10.3389/fonc.2024.1343004

2,275 views
1 citation

Original Research

Published on 29 Jan 2024

Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells

in Pharmacology of Anti-Cancer Drugs

Onyisi Christiana Didamson
Rahul Chandran
Heidi Abrahamse

Frontiers in Oncology

doi 10.3389/fonc.2024.1338802

1,882 views

Review

Published on 29 Jan 2024

Pediatric oncology drug development and dosage optimization

in Pharmacology of Anti-Cancer Drugs

S. Y. Amy Cheung
Justin L. Hay
Yu-Wei Lin
Rik de Greef
Julie Bullock

Frontiers in Oncology

doi 10.3389/fonc.2023.1235947

2,813 views
1 citation

Review

Published on 18 Jan 2024

Regulated cell death in glioma: promising targets for natural small-molecule compounds

in Pharmacology of Anti-Cancer Drugs

Mingyu Han
Sui Li
Huali Fan
Junsha An
Cheng Peng
Fu Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1273841

2,845 views
4 citations

Original Research

Published on 11 Jan 2024

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

in Pharmacology of Anti-Cancer Drugs

Yuanchu Lian
Xiating Li
Ying Lan
Zonghuai Li
Xiaoxin Lin
Jing’an Huang
Bo Zhang
Zhongwen Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1296511

1,539 views
3 citations

Editorial

Published on 04 Jan 2024

Editorial: Metal nanoparticles in cancer: detection, diagnosis, therapy and their pharmacological assessment

in Pharmacology of Anti-Cancer Drugs

Massimiliano Peana
Alexandros G. Georgakilas

Frontiers in Oncology

doi 10.3389/fonc.2023.1344197

809 views

Original Research

Published on 03 Jan 2024

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy

in Pharmacology of Anti-Cancer Drugs

Edson Alves de Lima Junior
Alexandre Abilio de Souza Teixeira
Loreana Sanches Silveira
Queralt Jové
Natalia Álvarez Ladrón
Marcelo G. Pereira
Francisco Javier López-Soriano
Josep M. Argilés
Patrícia Chakur Brum
Silvia Busquets

Frontiers in Oncology

doi 10.3389/fonc.2023.1237709

1,554 views

Review

Published on 19 Dec 2023

Active components of Solanum nigrum and their antitumor effects: a literature review

in Pharmacology of Anti-Cancer Drugs

Han Zhang
Jun-lin Lv
Qiu-sheng Zheng
Jie Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1329957

3,315 views
3 citations

Review

Published on 13 Dec 2023

Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck

in Pharmacology of Anti-Cancer Drugs

Prashant Puttagunta
Saagar V. Pamulapati
James E. Bates
Jennifer H. Gross
William A. Stokes
Nicole C. Schmitt
Conor Steuer
Yong Teng
Nabil F. Saba

Frontiers in Oncology

doi 10.3389/fonc.2023.1310106

2,438 views
2 citations

Review

Published on 12 Dec 2023

The renal damage and mechanisms relevant to antitumoral drugs

in Pharmacology of Anti-Cancer Drugs

Jiyu Tang
Nan Yang
Shujun Pan
Peiyao Ren
Maosheng Chen
Juan Jin
Qiang He
Yuqun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1331671

1,552 views
1 citation

Retraction

Published on 07 Dec 2023

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

in Pharmacology of Anti-Cancer Drugs

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1337635

943 views

Navigation group

Articles

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

Corrigendum: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy

Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells

Pediatric oncology drug development and dosage optimization

Regulated cell death in glioma: promising targets for natural small-molecule compounds

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

Editorial: Metal nanoparticles in cancer: detection, diagnosis, therapy and their pharmacological assessment

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy

Active components of Solanum nigrum and their antitumor effects: a literature review

Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck

The renal damage and mechanisms relevant to antitumoral drugs

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin